Skip to main content
. 2022 Jul;23(7):2233–2241. doi: 10.31557/APJCP.2022.23.7.2233

Figure 4.

Figure 4

Kaplan-Meier Actuarial Curve regarding Survival Analysis Related to the Expression of miR-145-3p, miR-101-3p, and VEGF in Patients with Cholangiocarcinoma